MTF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.94020000066075E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.22060000387714E-08 |
Normal-vs-Stage2 |
3.463700E-03 |
Normal-vs-Stage3 |
4.0942000001376E-07 |
Normal-vs-Stage4 |
1.52543999999422E-05 |
Stage1-vs-Stage2 |
8.589200E-01 |
Stage1-vs-Stage3 |
7.394600E-01 |
Stage1-vs-Stage4 |
7.348000E-01 |
Stage2-vs-Stage3 |
6.975400E-01 |
Stage2-vs-Stage4 |
9.799200E-01 |
Stage3-vs-Stage4 |
5.644400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.02250005421467E-09 |
Normal-vs-AfricanAmerican |
6.2522999999981E-05 |
Normal-vs-Asian |
1.51360999999239E-05 |
Caucasian-vs-AfricanAmerican |
8.878400E-01 |
Caucasian-vs-Asian |
9.582200E-02 |
AfricanAmerican-vs-Asian |
7.155700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.61390000036543E-07 |
Normal-vs-Female |
7.28149762707631E-11 |
Male-vs-Female |
1.163580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.257000E-03 |
Normal-vs-Age(41-60Yrs) |
2.00100003233672E-09 |
Normal-vs-Age(61-80Yrs) |
2.55190000020278E-07 |
Normal-vs-Age(81-100Yrs) |
7.256000E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.817600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.611400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.681420E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.257770E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.433650E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.054000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.58719999998613E-06 |
Normal-vs-Grade 2 |
2.74889999651862E-10 |
Normal-vs-Grade 3 |
2.26010000003996E-06 |
Normal-vs-Grade 4 |
5.225700E-04 |
Grade 1-vs-Grade 2 |
3.908200E-01 |
Grade 1-vs-Grade 3 |
1.020360E-02 |
Grade 1-vs-Grade 4 |
2.236200E-02 |
Grade 2-vs-Grade 3 |
6.064900E-03 |
Grade 2-vs-Grade 4 |
2.385600E-02 |
Grade 3-vs-Grade 4 |
8.248000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.92350049619006E-10 |
Normal-vs-ccB subtype |
4.86349999995195E-06 |
ccA subtype-vs-ccB subtype |
7.702400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.45800004981123E-09 |
Normal-vs-N1 |
9.340000E-03 |
N0-vs-N1 |
7.362800E-01 |
|
|